Tectonic Therapeutic, Inc. (TECX) stock
TECXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$21.04−0.92 (-4.19%)
Close on Nov 12, 2026Market cap $411.32MP/E –Yield 0.00%
Tectonic Therapeutic total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Tectonic Therapeutic's total debt was $0 at Dec 31, 2023. For fiscal 2023 it was $0, down 100.0% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $0 | -100.0% |
| FY2022 | Dec 31, 2022 | $15.28M | +2.2% |
| FY2021 | Dec 31, 2021 | $14.95M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2023 | Dec 31, 2023 | $0 | -100.0% |
| Q3 FY2023 | Sep 30, 2023 | $0 | -100.0% |
| Q2 FY2023 | Jun 30, 2023 | $0 | -100.0% |
| Q1 FY2023 | Mar 31, 2023 | $15.36M | +2.2% |
| Q4 FY2022 | Dec 31, 2022 | $15.28M | +2.2% |
| Q3 FY2022 | Sep 30, 2022 | $15.21M | – |
| Q2 FY2022 | Jun 30, 2022 | $15.10M | – |
| Q1 FY2022 | Mar 31, 2022 | $15.02M | – |
| Q4 FY2021 | Dec 31, 2021 | $14.95M | – |
See a number that looks wrong?